AERO-002
Phase 1Small molecule
AERO-002 is one of 3 small molecule programs targeting COPD (Chronic Obstructive Pulmonary Disease). It is currently in Phase 1.
1
Indications
2
Total Trials
1
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
3 competitors in COPD (chronic Obstructive Pulmonary Disease)
#DrugCompanyPhaseTrials
1Inhaled Prostacyclin
United TherapeuticsPhase 2
Inhaled Treprostinil
United TherapeuticsPhase 2
AERO-002
AAeroRx Therapeutics Inc.
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for AERO-002. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 1[1]
- Company
- AAeroRx Therapeutics Inc.